Pluri (PLUR) Depreciation & Amortization (CF) (2010 - 2025)
Pluri (PLUR) reported Depreciation & Amortization (CF) of $129000.0 for Q4 2025, up 89.71% year-over-year from $68000.0 in Q4 2024, and down 0.77% quarter-over-quarter from $130000.0 in Q3 2025.
Pluri (PLUR) Depreciation & Amortization (CF) (2010 - 2025) Analysis & Trends
Pluri (PLUR) has 16 years of Depreciation & Amortization (CF) data on file, last reported at $129000.0 in Q4 2025.
- Depreciation & Amortization (CF) for Q4 2025 came in at $129000.0, up 89.71% year-over-year; the trailing twelve-month figure through Dec 2025 was $412000.0 (up 61.57% YoY), and the FY2025 annual result was $316000.0, up 24.9% from the prior year.
- Depreciation & Amortization (CF) declined to $129000.0 in Q4 2025 per PLUR's latest filing, from $130000.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $339000.0 in Q1 2021 and troughed at $61000.0 in Q1 2024.
- A 5-year average of $144400.0 and a median of $92500.0 in 2022 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2022 and 2025: Depreciation & Amortization (CF) sank 70.34% in 2022, then jumped 100.0% in 2025.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $327000.0 in 2021, then slumped by 70.34% to $97000.0 in 2022, then plunged by 34.02% to $64000.0 in 2023, then gained by 6.25% to $68000.0 in 2024, then surged by 89.71% to $129000.0 in 2025.
- Business Quant data shows PLUR's Depreciation & Amortization (CF) at $129000.0 in Q4 2025, $130000.0 in Q3 2025, and $81000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 1,395.22 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 55.90 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 429,663.65 |
| 10 | Pluri | 21.39 Mn | 21.87 Mn | 86,000.00 | 129,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 129,000.00 |
| Dec 31, 2025 | 129,000.00 |
| Sep 30, 2025 | 130,000.00 |
| Sep 30, 2025 | 130,000.00 |
| Jun 30, 2025 | 81,000.00 |
| Jun 30, 2025 | 81,000.00 |
| Mar 31, 2025 | 72,000.00 |
| Mar 31, 2025 | 72,000.00 |
| Dec 31, 2024 | 68,000.00 |
| Dec 31, 2024 | 68,000.00 |
| Sep 30, 2024 | 65,000.00 |
| Sep 30, 2024 | 65,000.00 |
| Jun 30, 2024 | 61,000.00 |
| Jun 30, 2024 | 61,000.00 |
| Mar 31, 2024 | 61,000.00 |
| Mar 31, 2024 | 61,000.00 |
| Dec 31, 2023 | 64,000.00 |
| Dec 31, 2023 | 64,000.00 |
| Sep 30, 2023 | 67,000.00 |
| Sep 30, 2023 | 67,000.00 |